Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 20060575)

1.

Notch 1 signaling is active in ovarian cancer.

Rose SL, Kunnimalaiyaan M, Drenzek J, Seiler N.

Gynecol Oncol. 2010 Apr;117(1):130-3. doi: 10.1016/j.ygyno.2009.12.003. Epub 2010 Jan 8.

PMID:
20060575
2.
3.

Down-regulation of Notch1 by gamma-secretase inhibition contributes to cell growth inhibition and apoptosis in ovarian cancer cells A2780.

Wang M, Wu L, Wang L, Xin X.

Biochem Biophys Res Commun. 2010 Feb 26;393(1):144-9. doi: 10.1016/j.bbrc.2010.01.103. Epub 2010 Feb 1.

PMID:
20117093
4.

Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells.

Wang Z, Zhang Y, Li Y, Banerjee S, Liao J, Sarkar FH.

Mol Cancer Ther. 2006 Mar;5(3):483-93.

5.

RNAi-mediated knockdown of Notch-1 leads to cell growth inhibition and enhanced chemosensitivity in human breast cancer.

Zang S, Chen F, Dai J, Guo D, Tse W, Qu X, Ma D, Ji C.

Oncol Rep. 2010 Apr;23(4):893-9.

PMID:
20204271
6.

Notch1 expression correlates with tumor differentiation status in ovarian carcinoma.

Wang M, Wang J, Wang L, Wu L, Xin X.

Med Oncol. 2010 Dec;27(4):1329-35. doi: 10.1007/s12032-009-9384-8. Epub 2009 Dec 11.

PMID:
20012562
7.

CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.

Manzano RG, Montuenga LM, Dayton M, Dent P, Kinoshita I, Vicent S, Gardner GJ, Nguyen P, Choi YH, Trepel J, Auersperg N, Birrer MJ.

Oncogene. 2002 Jun 27;21(28):4435-47.

8.

Bcl-X(L) is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells.

Dodier P, Piché A.

Gynecol Oncol. 2006 Feb;100(2):254-63. Epub 2005 Sep 26.

PMID:
16188300
9.

Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.

Ma X, Wang S, Zhou J, Xing H, Xu G, Wang B, Chen G, Lu YP, Ma D.

Oncol Rep. 2005 Jul;14(1):275-9.

PMID:
15944801
10.

E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.

Reimer D, Hubalek M, Riedle S, Skvortsov S, Erdel M, Concin N, Fiegl H, Müller-Holzner E, Marth C, Illmensee K, Altevogt P, Zeimet AG.

Cancer Res. 2010 Jun 1;70(11):4613-23. doi: 10.1158/0008-5472.CAN-09-3551. Epub 2010 May 11.

11.

Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells.

Gery S, Xie D, Yin D, Gabra H, Miller C, Wang H, Scott D, Yi WS, Popoviciu ML, Said JW, Koeffler HP.

Clin Cancer Res. 2005 Oct 15;11(20):7243-54.

12.

Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.

Greenblatt DY, Vaccaro AM, Jaskula-Sztul R, Ning L, Haymart M, Kunnimalaiyaan M, Chen H.

Oncologist. 2007 Aug;12(8):942-51.

13.
15.

Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo.

Sjölund J, Johansson M, Manna S, Norin C, Pietras A, Beckman S, Nilsson E, Ljungberg B, Axelson H.

J Clin Invest. 2008 Jan;118(1):217-28.

16.
17.

Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.

Kikuchi R, Tsuda H, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J, Imoto I.

Cancer Res. 2007 Aug 1;67(15):7095-105.

18.

[Correlation of autophagy gene Beclin1 to tumorigenesis and development of epithelial ovarian cancer].

Duan ZL, Peng ZL, Wang ZH, Yan NH.

Ai Zheng. 2007 Mar;26(3):258-63. Chinese.

PMID:
17355787
19.

Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer.

Wang Z, Sengupta R, Banerjee S, Li Y, Zhang Y, Rahman KM, Aboukameel A, Mohammad R, Majumdar AP, Abbruzzese JL, Sarkar FH.

Cancer Res. 2006 Aug 1;66(15):7653-60.

20.

Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.

Donninger H, Bonome T, Radonovich M, Pise-Masison CA, Brady J, Shih JH, Barrett JC, Birrer MJ.

Oncogene. 2004 Oct 21;23(49):8065-77.

PMID:
15361855
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk